Trial Profile
Clinical Trials Insight: 700029839
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2008
Price :
$35
*
At a glance
- Drugs Resveratrol (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Sirtris
- 18 Apr 2008 Full results will be presented at the American Diabetes Association annual meeting in June.
- 18 Apr 2008 Top-line results reported in a Sirtris media release.
- 11 Jan 2008 New trial record.